medigraphic.com
ISSN 1727-897X (Electronic)

2012, Number 3

<< Back Next >>

Medisur 2012; 10 (3)

Non-compliance with Drug Therapy in Patients with Primary Open-angle Glaucoma

Fernández GA, Triana CI, Lam DRM, Villar VR

Language: Spanish
References: 16
Page: 27-31
PDF size: 105.06 Kb.


ABSTRACT

Background: Early treatment and patient’s compliance with this treatment are the most effective ways of identify the behavior of patients' compliance or non compliance with the treatment in cases of primary openangle glaucoma. Methods: A descriptive and cross sectional study was conducted including 106 patients with confirmed primary open-angle glaucoma who were treated at the Glaucoma Service of the Dr. Salvador Allende Hospital in Havana during the first quarter of 2011. We analyzed the following variables: age, sex, educational level, personal pathological antecedents and family history of glaucoma, treatment and treatment compliance and self-reported general health condition and vision. Results: Average age among patients was 60.7 years old, 72.7% were women and 51.9% did not comply with drug treatment. 91, 6% of patients used monotherapy and 73.6% used timolol alone or in combination with another drug. 68, 9% had a family history of glaucoma. Hypertension (51, 1%) was the most commonly reported chronic disease. The most referred self-assessment of general health and vision was that of regular (42, 5% and 49, 1% respectively). Conclusions: More than half of patients did not comply with drug therapy as indicated for the control of the disease. This behavior was associated with age in the cases included in this study.


REFERENCES

  1. Eldaly M, Hunter M, Khafagy M. The socioeconomic impact among Egyptian glaucoma patients. Br J Ophthalmol. 2007;91:1274-5.

  2. Salgado Paris J, Castro Salas M. El adulto mayor con glaucoma, una necesidad urgente para promover su autocuidado. Cienc Enferm. 2008;XIV(1):17-22.

  3. Detry-Morel M. Compliance et persistance. J Fr Ophtalmol. 2006;2:216-25.

  4. Gutiérrez Pérez I, Gordon Vega MA. Tratamiento del glaucoma. Boletín de uso racional del medicamento[revista en Internet]. 2004[citado 6 Abr 2010];XII(2):[aprox. 10 p.]. Disponible en: http://www.scsalud.es/publicaciones/ descargar.php?Id=4&Id2=2.

  5. Brandão Vilela de Castro AN, Araújo MW. Não-adesão à terapêutica medicamentosa do glaucoma. Arq Bras Oftalmol. 2008;71(2):207-14.

  6. Tripop S, Pratheepawanit N, Asawaphureekorn S, Anutangkoon W, Inthayung S. Health related quality of life instruments for glaucoma: a comprehensive review. J Med Assoc Thai. 2005;88(Suppl 9):S155-62.

  7. Severn P, Fraser S, Finch T, May C. Which quality of life score is best for glaucoma patients and why? BMC Ophthalmology[ revista en Internet]. 2008[citada 6 Abr 2011];2:[aprox. 10 p.]. Disponible en: http:// www.biomedcentral.com/1471-2415/8/2.

  8. Traverso CE, Walt JG, Stern LS, Dolgitser M. Pharmacotherapy Compliance in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma. Journal of Ocular Pharmacology and Therapeutics. 2009;25(1):77-82.

  9. Khandekar R, Shama Mel S, Mohammed AJ. Noncompliance with medical treatment among glaucoma patients in Oman-a cross-sectional descriptive study. Ophthalmic Epidemiol. 2005;12(5):303-9.

  10. 10.Kanski JJ. Oftalmología clínica. 5ta ed. Madrid: Mosby; 2005.

  11. 11.Nordmann JP, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75.

  12. 12.Jampel HD. Glaucoma patients’ assessment of their visual function and quality of life. Tr Am Ophth Soc. 2001;99:301-17.

  13. 13.Hatt S, Wormald R, Burr J. Cribado para la prevención del daño al nervio óptico debido al glaucoma de ángulo abierto crónico. Biblioteca Cochrane Plus[revista en Internet]. 2008[citado 6 Abr 2011];2:[aprox. 20 p]. Disponible en: http://www.update-software.com/BCP/BCPGetDocument.asp?DocumentID=CD006129.

  14. 14.Leske MC. Open-angle glaucoma-an epidemiologic overview. Ophthalmol Epidemiol. 2007;14(4):166-72.

  15. 15.Labrada Rodríguez YH. Evaluación de los factores de riesgo en el glaucoma primario de ángulo abierto. Rev Cub Oftalmol[revista en Internet]. 2008[citada 6 Jun 2011];21(1):[aprox. 8 p.]. Disponible en: http://bvs.sld.cu/ revistas/oft/vol21_1_08/oft13108.htm.

  16. 16.Carrasco Font C, Lorenzo Martínez S, Gili Manzanaro P, Arias Puente A, Andrés Alba Y, Matilla Rodríguez A, et al. Influencia de la función visual en la calidad de vida de los pacientes con glaucoma. Arch Soc Esp Oftalmol[revista en Internet]. 2008[citado 27 Ene 2010];83(4):[aprox. 8 p.]. Disponible en:http://scielo.isciii.es/scielo.php? pid=S0365-66912008000400007&script=sci_arttext.




2020     |     www.medigraphic.com